Strata Critical Medical, Inc. SRTA
5.33
0.06
1.14%
as of 25 Sep
- Market cap
- $476.8M
- P/E
- 10.5×
Follow SRTA
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
15.64% | 16.51% | 18.59% | 16.01% | |
| 13.07% | 14.21% | 16.26% | 13.62% | ||
ROIC |
(2.83%) | (6.42%) | (5.42%) | (4.98%) | |
Return on Tangible Assets |
30.33% | 28.95% | 32.80% | 34.69% | |
Average Days of Receivables |
112.63 | 73.98 | 63.24 | 61.89 | |
Free Cash Flow per Share |
(0.68) | (0.73) | (0.68) | (0.57) | |
Free Cash Flow |
(56.40) | (59.92) | (58.13) | (49.52) | |
Capital Expenditures |
(14.04) | (11.01) | (13.34) | (13.48) | |
Piotroski F-Score |
2.00 | 4.00 | 4.00 | 4.00 | |
| Other line items | |||||
Cash ROIC |
(11.79%) | (14.36%) | (12.99%) | (11.92%) | |
Accounts Receivable Turnover |
3.92 | 6.60 | 7.41 | 7.15 | |
Accounts Payable Turnover |
4.55 | 11.00 | 11.84 | 12.58 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
100.98 | 44.78 | 40.38 | 33.28 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
2.72% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
26.48% | 30.88% | 28.06% | 25.34% | |
Share Based Compensation of Revenue |
12.97% | 9.05% | 8.16% | 6.64% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
(1.05) | (1.18) | (0.95) | (0.90) | |
Depreciation/Fixed assets |
0.17 | 0.22 | 0.24 | 0.40 | |
Capex/Depreciation |
(2.09) | (1.35) | (1.40) | (0.83) | |
Revenue per Share |
1.48 | 2.40 | 2.68 | 2.97 | |
Operating CF per Share |
(0.51) | (0.60) | (0.52) | (0.42) | |
Capex per Share |
(0.17) | (0.13) | (0.16) | (0.16) | |
Capex to Sales |
0.12 | 0.06 | 0.06 | 0.05 | |
Net Profit Margin |
33.20% | 20.97% | 20.56% | 15.71% |
Columns are period end dates